ICD-10 Code C91.00
Acute lymphoblastic leukemia not having achieved remission
C91.00 is a specific medical classification code used for acute lymphoblastic leukemia not having achieved remission. Acute lymphoblastic leukemia, also known as acute lymphocytic leukemia or acute lymphoid leukemia, is a rapidly progressing cancer of the blood and bone marrow characterized by the overproduction of immature white blood cells called lymphoblasts. The designation of not having achieved remission signifies that the patient has active disease, which applies to individuals with a new diagnosis prior to successful treatment, those currently undergoing induction therapy, or patients who have experienced a disease relapse. This code encompasses various biological subtypes, including precursor B-cell acute lymphoblastic leukemia and T-cell acute lymphoblastic leukemia, as well as acute lymphoblastic lymphoma presenting with significant bone marrow involvement. Clinically, patients categorized under this code often present with symptoms stemming from bone marrow failure and organ infiltration, such as fatigue, anemia, severe neutropenia leading to recurrent infections, thrombocytopenia causing easy bruising or bleeding, bone pain, lymphadenopathy, and hepatosplenomegaly. Related conditions and diagnostic overlaps include precursor cell lymphoblastic leukemia, acute biphenotypic leukemia, and other acute lymphoid neoplasms in an active, non-remission state.
- Acute lymphoblastic leukemia with failed remission
- Acute lymphoblastic leukemia NOS
C91.00 is a valid billable ICD-10 diagnosis code for Acute lymphoblastic leukemia not having achieved remission. It is found in the 2027 version of the ICD-10 CM Index and can be used in all HIPAA-covered transactions from Oct 01, 2026 - Sep 30, 2027.
Check for any exclusions, inclusions or special notations associated with C91.00
C91.00 also applies to the following:
- Acute lymphoblastic leukemia with failed remission
- Acute lymphoblastic leukemia NOS
See also, ICD-10 Table of Neoplasms.
- MDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms
Lymphoma and Leukemia with Major Procedure - MDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms
Acute Leukemia without Major Procedure - MDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms
Chemotherapy
ICD-10 code C91.00 is based on the following Tabular structure:
Chapter 2: Neoplasms- Section C81-C96: Malignant neoplasms of lymphoid, hematopoietic and related tissue
- Category C91: Lymphoid leukemia
↑ Parent code:
C91.0 for Acute lymphoblastic leukemia [ALL]
Should you use C91.00 or C9100 (with or without decimal point) when submitting claims?
DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you
but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically.
This note further define, or give examples of, the content of the code or category.
List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of “other specified” codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.
A type 1 Excludes note is a pure excludes. It means 'NOT CODED HERE!' An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
A type 2 Excludes note represents 'Not included here'. An Excludes2 note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When an Excludes2 note appears under a code it is acceptable to use both the code and the excluded code together.
A “code also” note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction. The sequencing depends on the circumstances of the encounter.
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.